Cessatech A/S vs Orphazyme A/S
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Orphazyme A/S is the larger company by market value: $7 M against $4 M for Cessatech A/S, 1.8 times as much (market caps of Jul 30, 2023 for Cessatech A/S and Jan 5, 2024 for Orphazyme A/S). Cessatech A/S's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Orphazyme A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Side by side
| Measure | Cessatech A/S 8GN.F | Orphazyme A/S ORPHA.CO |
|---|---|---|
| Profile | ||
| Country | 🇩🇰 Denmark | 🇩🇰 Denmark |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Revenue | — | $0 M |
| Net income | — | $-101 M |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jul 2023 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Cessatech A/S or Orphazyme A/S?
Orphazyme A/S is the larger company by market value: $7 M against $4 M for Cessatech A/S, 1.8 times as much (market caps of Jul 30, 2023 for Cessatech A/S and Jan 5, 2024 for Orphazyme A/S). Cessatech A/S's value is the last on file, from Jul 30, 2023: no market-data feed is connected for its exchange yet. Orphazyme A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Cessatech A/S
More about Orphazyme A/S
Sources#
Every figure on this page comes from these, with the date shown next to it.